Search

everythinglearnresearchcommunity

for

Search:↓

A man unhappy with his old hair restoration got a new, natural-looking hairline using a combination of follicular unit extraction and punch graft reduction.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

PRP with microneedling is more effective than PRP alone for treating hair loss.

Injections improve hair growth, density, and thickness in women safely.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

The Graft Quality Index grades hair transplant grafts to predict placement difficulty and surgery results.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Researchers created a standard system to grade hair damage using microscopic images.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

PCOS is linked to low-grade chronic inflammation.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Children with lower inhibitory control experience more stress when starting third grade.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.